Dr Ralf Heine

Experts / Dr Ralf Heine

Paediatric Gastroenterologist and Allergist; Clinical Researcher, Paediatric Allergy and Nutrition

Dr. Heine is trained in Paediatric Gastroenterology and Allergy at the Royal Children’s Hospital in Melbourne, Australia, where he worked as a Senior Staff Specialist from 1999 to 2017.As a clinician researcher at the University of Melbourne and the Murdoch Children’s Research Institute (MCRI), he was involved in several clinical trials on gastrointestinal food allergy, gastro-oesophageal reflux, and eosinophilic oesophagitis.From 2017 to 2023, Dr. Heine worked as the Global Clinical Development Lead in Paediatric Allergy at Nestlé Health Science in Switzerland, where he conducted clinical trials on hypoallergenic formulas and the gut microbiome in infants with cow’s milk allergy.In 2024, Dr. Heine returned to Australia and re-joined the MCRI in Melbourne as an Honorary Research Fellow.

HMOs and lactose for cow’s milk protein allergy

In this Product Explainer, Paediatric Gastroenterologist and Allergist, Dr Ralf Heine explains the role human milk oligosaccharides (HMOs) and lactose can play in nurturing the gut microbiome of formula-fed infants with cow’s milk protein allergy.

HMOs and lactose for cow’s milk protein allergy

In this Product Explainer, Paediatric Gastroenterologist and Allergist, Dr Ralf Heine explains the role human milk oligosaccharides (HMOs) and lactose can play in nurturing the gut microbiome of formula-fed infants with cow’s milk protein allergy.

By Dr Ralf Heine

Videos

Diet and nutrition, Gastroenterology, Paediatrics

Dr Ralf Heine

Paediatric Gastroenterologist and Allergist; Clinical Researcher, Paediatric Allergy and Nutrition

More from this expert

HMOs and lactose for cow’s milk protein allergy

In this Product Explainer, Paediatric Gastroenterologist and Allergist, Dr Ralf Heine explains the role human milk oligosaccharides (HMOs) and lactose can play in nurturing the gut microbiome of formula-fed infants with cow’s milk protein allergy.

HMOs and lactose for cow’s milk protein allergy

In this Product Explainer, Paediatric Gastroenterologist and Allergist, Dr Ralf Heine explains the role human milk oligosaccharides (HMOs) and lactose can play in nurturing the gut microbiome of formula-fed infants with cow’s milk protein allergy.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Dr Ralf Heine

Paediatric Gastroenterologist and Allergist; Clinical Researcher, Paediatric Allergy and Nutrition

More from this expert

HMOs and lactose for cow’s milk protein allergy

In this Product Explainer, Paediatric Gastroenterologist and Allergist, Dr Ralf Heine explains the role human milk oligosaccharides (HMOs) and lactose can play in nurturing the gut microbiome of formula-fed infants with cow’s milk protein allergy.

HMOs and lactose for cow’s milk protein allergy

In this Product Explainer, Paediatric Gastroenterologist and Allergist, Dr Ralf Heine explains the role human milk oligosaccharides (HMOs) and lactose can play in nurturing the gut microbiome of formula-fed infants with cow’s milk protein allergy.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.